MedTrace Logo

GAS Epi Study to Measure Age-Related Antibody Titers to J8 Vaccine

NCT00264784 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2007-12-28

No results posted yet for this study

Summary

The purpose of this ongoing study (Part V) is to evaluate the cause, distribution, control, and results of group A streptococcus infections (GAS) in Fiji. Patients of all ages presenting to the Colonial War Memorial Hospital, Suva, Fiji and patients donating blood to the Colonial War Memorial Hospital, Suva, Fiji may participate. Subject duration is less than one day. This study may help to develop a vaccine that will prevent group A streptococcal infections.

Conditions

  • Streptococcus Group A

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-12-31
Completion
2006-05-31

Countries

  • Fiji

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00264784 on ClinicalTrials.gov